JP2012516355A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012516355A5 JP2012516355A5 JP2011548305A JP2011548305A JP2012516355A5 JP 2012516355 A5 JP2012516355 A5 JP 2012516355A5 JP 2011548305 A JP2011548305 A JP 2011548305A JP 2011548305 A JP2011548305 A JP 2011548305A JP 2012516355 A5 JP2012516355 A5 JP 2012516355A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- optionally substituted
- hydrogen
- nitrile
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 11
- 125000000753 cycloalkyl group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 5
- 229910052736 halogen Inorganic materials 0.000 claims 5
- 150000002367 halogens Chemical group 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- -1 hydroxy, methoxy Chemical group 0.000 claims 5
- 150000002825 nitriles Chemical group 0.000 claims 5
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 150000003573 thiols Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 102100038354 Metabotropic glutamate receptor 4 Human genes 0.000 claims 1
- 125000000732 arylene group Chemical group 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 1
- 125000005724 cycloalkenylene group Chemical group 0.000 claims 1
- 125000002993 cycloalkylene group Chemical group 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 125000005549 heteroarylene group Chemical group 0.000 claims 1
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims 1
- 108010038422 metabotropic glutamate receptor 4 Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000005062 synaptic transmission Effects 0.000 claims 1
- 125000002813 thiocarbonyl group Chemical group *C(*)=S 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20627109P | 2009-01-28 | 2009-01-28 | |
| US61/206,271 | 2009-01-28 | ||
| PCT/US2010/022430 WO2010088406A1 (en) | 2009-01-28 | 2010-01-28 | Substituted 1,1,3,3-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012516355A JP2012516355A (ja) | 2012-07-19 |
| JP2012516355A5 true JP2012516355A5 (enExample) | 2013-04-11 |
Family
ID=42396011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011548305A Withdrawn JP2012516355A (ja) | 2009-01-28 | 2010-01-28 | ｍＧＬｕＲ４アロステリック増強剤としての置換された１，１，３，３−テトラオキシドベンゾ［ｄ］［１，３，２］ジチアゾール、組成物、および神経機能不全を治療する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8658650B2 (enExample) |
| EP (1) | EP2393785A4 (enExample) |
| JP (1) | JP2012516355A (enExample) |
| AU (1) | AU2010208176A1 (enExample) |
| CA (1) | CA2751176A1 (enExample) |
| IL (1) | IL214337A0 (enExample) |
| SG (1) | SG173465A1 (enExample) |
| WO (1) | WO2010088406A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2737699A1 (en) * | 2008-09-16 | 2010-03-25 | Merck Sharp & Dohme Corp. | Phthalimide derivative metabotropic glutamate r4 ligands |
| US8759377B2 (en) | 2009-11-23 | 2014-06-24 | Vanderbilt University | Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| EP2853532B1 (en) | 2013-09-28 | 2020-12-09 | Instytut Farmakologii Polskiej Akademii Nauk | 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III |
| AR098100A1 (es) * | 2013-10-22 | 2016-05-04 | Dow Agrosciences Llc | Composiciones plaguicidas y los métodos relacionados |
| WO2016115272A1 (en) | 2015-01-13 | 2016-07-21 | Vanderbilt University | Benzothiazole and benzisothiazole-substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| WO2016123629A1 (en) | 2015-01-30 | 2016-08-04 | Vanderbilt University | Indazole and azaindazole substituted compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| WO2016123627A1 (en) | 2015-01-30 | 2016-08-04 | Vanderbilt University | Isoquiniline and napthalene-substituted compounds as mglur4 allosteric potentiators, compounds, and methods of treating neurological dysfunction |
| WO2016179351A1 (en) | 2015-05-05 | 2016-11-10 | Northwestern University | Treatment of levodopa-induced dyskinesias |
| EP3419981A4 (en) | 2016-02-23 | 2019-09-18 | Indiana University Research & Technology Corporation | COMBINATION THERAPIES FOR THE TREATMENT OF SPINAL MUSCLE ATROPHY |
| US10710997B2 (en) | 2016-09-01 | 2020-07-14 | Vanderbilt University | Isoquinoline amide and isoquinoline amide-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| US10294222B2 (en) | 2016-09-01 | 2019-05-21 | Vanderbilt University | Benzomorpholine and benzomorpholine-substituted compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| US10968227B2 (en) | 2016-11-08 | 2021-04-06 | Vanderbilt University | Isoquinoline ether compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| US11242342B2 (en) | 2016-11-08 | 2022-02-08 | Vanderbilt University | Isoquinoline amine compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| US11319304B2 (en) | 2017-06-28 | 2022-05-03 | Vanderbilt University | Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| EP3668865A1 (en) | 2017-08-16 | 2020-06-24 | Vanderbilt University | Indazole compounds as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| KR102024361B1 (ko) * | 2017-09-26 | 2019-09-23 | 울산과학기술원 | 벤젠 디아민 유도체를 포함하는 퇴행성 뇌질환 예방 또는 치료용 조성물 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5187276A (en) * | 1983-06-18 | 1993-02-16 | Troponwerke Gmbh & Co. Kg. | 2-pyrimidinyl-1-piperazine derivatives |
| DE3321969A1 (de) | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| AUPR738301A0 (en) | 2001-08-30 | 2001-09-20 | Starpharma Limited | Chemotherapeutic agents |
| US7223788B2 (en) * | 2003-02-14 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
| EP1646377A4 (en) | 2003-07-11 | 2009-09-09 | Merck & Co Inc | TREATMENT OF MOVEMENT DISORDERS WITH METABOTROPIC GLUTAMATE 4 RECEPTOR POSITIVE ALLOSTERIC MODULATOR |
| US20050250803A1 (en) | 2003-11-26 | 2005-11-10 | Pfizer Inc | Combination of dopamine agonists and monoamine reuptake inhibitors |
| US20060004001A1 (en) | 2004-02-27 | 2006-01-05 | Merz Pharma Gmbh & Co., Kgaa | Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors |
| WO2008066887A2 (en) * | 2006-11-30 | 2008-06-05 | Albert Einstein College Of Medicine Of Yeshiva University | Small molecule inhibitors of bcl6 |
| CA2737699A1 (en) | 2008-09-16 | 2010-03-25 | Merck Sharp & Dohme Corp. | Phthalimide derivative metabotropic glutamate r4 ligands |
| AU2010275477A1 (en) | 2009-07-23 | 2012-02-23 | Vanderbilt University | Substituted benzoimidazolesulfonamides and substituted indolesulfonamides as mGluR4 potentiators |
| IN2012DN02580A (enExample) | 2009-09-04 | 2015-08-28 | Univ Vanderbilt | |
| JP2013508413A (ja) | 2009-10-22 | 2013-03-07 | ヴァンダービルト ユニバーシティー | ｍＧｌｕＲ４アロステリック増強剤、組成物、および神経機能不全を治療する方法 |
| BR112012010738A2 (pt) | 2009-11-06 | 2019-09-24 | Univ Vanderbilt | ''aril e heteroaril sulfonas como potenciadores alostéricos de mglur4,composições e métodos de tratamento de disfunção neurológica'' |
| AU2011215638B2 (en) | 2010-02-11 | 2016-04-28 | Vanderbilt University | Pyrazolopyridine, pyrazolopyrazine, pyrazolopyrimidine, pyrazolothiophene and pyrazolothiazole compounds as mGluR4 allosteric potentiators, compounds, and methods of treating neurological dysfunction |
| JP2013519685A (ja) | 2010-02-11 | 2013-05-30 | ヴァンダービルト ユニバーシティー | ｍＧｌｕＲ４アロステリック増強剤としてのベンズイソオキサゾール類およびアザベンズイソオキサゾール類、組成物、および神経機能不全を治療する方法 |
| KR20130079429A (ko) | 2010-05-12 | 2013-07-10 | 벤더르빌트 유니버시티 | 헤테로시클릭 설폰 mglur4 알로스테릭 강화제, 조성물 및 신경 기능이상을 치료하는 방법 |
-
2010
- 2010-01-28 US US13/146,909 patent/US8658650B2/en active Active
- 2010-01-28 JP JP2011548305A patent/JP2012516355A/ja not_active Withdrawn
- 2010-01-28 CA CA2751176A patent/CA2751176A1/en not_active Abandoned
- 2010-01-28 EP EP10736412.7A patent/EP2393785A4/en not_active Withdrawn
- 2010-01-28 SG SG2011054608A patent/SG173465A1/en unknown
- 2010-01-28 AU AU2010208176A patent/AU2010208176A1/en not_active Abandoned
- 2010-01-28 WO PCT/US2010/022430 patent/WO2010088406A1/en not_active Ceased
-
2011
- 2011-07-28 IL IL214337A patent/IL214337A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012516355A5 (enExample) | ||
| JP2010510177A5 (enExample) | ||
| JP2013102146A5 (ja) | 化合物 | |
| AR124117A2 (es) | Agentes inductores de la apoptosis que pueden usarse para tratar el cáncer y las enfermedades inmunes y autoinmunes | |
| JP2014209611A5 (ja) | 化合物 | |
| JP2014526533A5 (enExample) | ||
| JP2017518281A5 (enExample) | ||
| JP2013512915A5 (enExample) | ||
| JP2013519685A5 (enExample) | ||
| JP2013010731A5 (ja) | 複素環化合物 | |
| JP2013519684A5 (enExample) | ||
| JP2011006405A5 (ja) | 化合物 | |
| JP2013010749A5 (ja) | カルバゾール化合物 | |
| JP2011527667A5 (enExample) | ||
| JP2013100341A5 (enExample) | ||
| JP2015042636A5 (ja) | 有機化合物 | |
| JP2016520672A5 (enExample) | ||
| JP2015063518A5 (ja) | 有機化合物 | |
| JP2005289914A5 (enExample) | ||
| JP2010095546A5 (enExample) | ||
| JP2012515776A5 (enExample) | ||
| JP2012006912A5 (ja) | トリアゾール誘導体 | |
| JP2010504286A5 (enExample) | ||
| JP2015508092A5 (enExample) | ||
| JP2017155040A5 (enExample) |